China Neurology Devices Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD08378
Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 128
Buy this product or for assistance call +44 20 7060 7474

This report is an essential source for in-depth information and data relating to China neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in China

Scope

  • The report provides neurology devices information broken down into detailed categories and segments in China.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the neurology devices market in China.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Neurology Devices
    • 3.2 CSF Management
      • 3.2.1 Hydrocephalus Shunts
      • 3.2.2 ICP Monitoring Devices
    • 3.3 Interventional Neurology
      • 3.3.1 Aneurysm Clips
      • 3.3.2 Embolic Systems
      • 3.3.3 Navigational Systems
    • 3.4 Neurostimulation Devices
      • 3.4.1 Deep Brain Stimulators
      • 3.4.2 Spinal Cord Stimulators
      • 3.4.3 Vagus Nerve Stimulators
    • 3.5 Neurosurgical Products
      • 3.5.1 Neuroendoscopes
    • 3.6 Radiosurgery
      • 3.6.1 CyberKnife Radiosurgery
      • 3.6.2 GammaKnife Radiosurgery
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
      • 4.2.1 Healthcare Personnel Data
      • 4.2.2 Healthcare Facilities Data
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Registration and Conformity assessment
      • 5.1.3 China Compulsory Certificate (CCC Mark)
      • 5.1.4 Labeling and Packaging
      • 5.1.5 Registration Fee
      • 5.1.6 Registration Period
    • 5.2 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 Neurology Devices In China
    • 8.1 Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Neurology Devices, China, Overall Revenue ($ mn), 2000-2015
    • 8.3 Neurology Devices, China, Category Volume (Units), 2000-2015
    • 8.4 Neurology Devices, China, Company Share (2006-2007)
  • 9 CSF Management In China
    • 9.1 CSF Management Overall Revenue (2000-2015)
    • 9.2 CSF Management Overall Volume (2000-2015)
    • 9.3 CSF Management Average Price (2000-2015)
    • 9.4 CSF Management Distribution Share (2007-2008)
    • 9.5 CSF Management, China, Company Share (2006-2007)
  • 10 Interventional Neurology In China
    • 10.1 Interventional Neurology Overall Revenue (2000-2015)
      • 10.1.1 Embolic Systems Overall Revenue (2000-2015)
      • 10.1.2 Navigational Systems Overall Revenue (2000-2015)
    • 10.2 Interventional Neurology Overall Volume (2000-2015)
      • 10.2.1 Embolic Systems Overall Volume (2000-2015)
      • 10.2.2 Navigational Systems Overall Volume (2000-2015)
    • 10.3 Interventional Neurology Average Price (2000-2015)
    • 10.4 Interventional Neurology Distribution Share (2007-2008)
    • 10.5 Interventional Neurology, China, Company Share (2006-2007)
  • 11 Neurostimulation Devices In China
    • 11.1 Neurostimulation Devices Overall Revenue (2000-2015)
    • 11.2 Neurostimulation Devices Overall Volume (2000-2015)
    • 11.3 Neurostimulation Devices Average Price (2000-2015)
    • 11.4 Neurostimulation Devices Distribution Share (2007-2008)
    • 11.5 Neurostimulation Devices, China, Company Share (2006-2007)
  • 12 Neurosurgical Products In China
    • 12.1 Neurosurgical Products Overall Revenue (2000-2015)
    • 12.2 Neurosurgical Products Overall Volume (2000-2015)
    • 12.3 Neurosurgical Products Average Price (2000-2015)
    • 12.4 Neurosurgical Products Distribution Share (2007-2008)
    • 12.5 Neurosurgical Products, China, Company Share (2006-2007)
  • 13 Radiosurgery In China
    • 13.1 Radiosurgery Overall Revenue (2000-2015)
    • 13.2 Radiosurgery Overall Volume (2000-2015)
    • 13.3 Radiosurgery Average Price (2000-2015)
    • 13.4 Radiosurgery Distribution Share (2007-2008)
    • 13.5 Radiosurgery, China, Company Share (2006-2007)
  • 14 Overview of Key Companies in China Neurology Devices Market
    • 14.1 Medtronic, Inc. Company Profile
      • 14.1.1 Company Overview
      • 14.1.2 Value Chain Analysis
        • 14.1.2.1 Manufacturing
        • 14.1.2.2 Product Development
        • 14.1.2.3 Sales and Marketing
      • 14.1.3 Medtronic, Inc. Pipeline Products
        • 14.1.3.1 Medtronic, Inc. Pipeline Products By Equipment Type
        • 14.1.3.2 Medtronic, Inc. Pipeline Products By Development Stage
        • 14.1.3.3 Medtronic, Inc. Pipeline Products By Therapy Area
        • 14.1.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials
        • 14.1.3.5 Medtronic, Inc. Pipeline Products By News Summary
    • 14.2 Boston Scientific Corporation Company Profile
      • 14.2.1 Company Overview
      • 14.2.2 Value Chain Analysis
        • 14.2.2.1 Manufacturing
        • 14.2.2.2 Product Development
        • 14.2.2.3 Sales and Marketing
      • 14.2.3 Boston Scientific Corporation Pipeline Products
        • 14.2.3.1 Boston Scientific Corporation Pipeline Products By Equipment Type
        • 14.2.3.2 Boston Scientific Corporation Pipeline Products By Development Stage
        • 14.2.3.3 Boston Scientific Corporation Pipeline Products By Therapy Area
        • 14.2.3.4 Boston Scientific Corporation Pipeline Products By Clinical Trials
        • 14.2.3.5 Boston Scientific Corporation Pipeline Products By News Summary
    • 14.3 Cordis Corporation Company Profile
      • 14.3.1 Company Overview
    • 14.4 Elekta AB Company Profile
      • 14.4.1 Company Overview
      • 14.4.2 Value Chain Analysis
        • 14.4.2.1 Manufacturing
        • 14.4.2.2 Product Development
        • 14.4.2.3 Sales and Marketing
      • 14.4.3 Elekta AB Pipeline Products
        • 14.4.3.1 Elekta AB Pipeline Products By Equipment Type
        • 14.4.3.2 Elekta AB Pipeline Products By Development Stage
        • 14.4.3.3 Elekta AB Pipeline Products By Therapy Area
        • 14.4.3.4 Elekta AB Pipeline Products By News Summary
    • 14.5 Cyberonics, Inc. Company Profile
      • 14.5.1 Company Overview
      • 14.5.2 Cyberonics, Inc. Pipeline Products
        • 14.5.2.1 Cyberonics, Inc. Pipeline Products By Equipment Type
        • 14.5.2.2 Cyberonics, Inc. Pipeline Products By Development Stage
        • 14.5.2.3 Cyberonics, Inc. Pipeline Products By Therapy Area
    • 14.6 ev3 Inc. Company Profile
      • 14.6.1 Company Overview
      • 14.6.2 Value Chain Analysis
        • 14.6.2.1 Manufacturing
        • 14.6.2.2 Product Development
        • 14.6.2.3 Sales and Marketing
      • 14.6.3 ev3 Inc. Pipeline Products
        • 14.6.3.1 ev3 Inc. Pipeline Products By Equipment Type
        • 14.6.3.2 ev3 Inc. Pipeline Products By Development Stage
        • 14.6.3.3 ev3 Inc. Pipeline Products By Therapy Area
        • 14.6.3.4 ev3 Inc. Pipeline Products By Clinical Trials
        • 14.6.3.5 ev3 Inc. Pipeline Products By News Summary
    • 14.7 B. Braun Melsungen AG
      • 14.7.1 Company Overview
      • 14.7.2 Value Chain Analysis
        • 14.7.2.1 Manufacturing
        • 14.7.2.2 Product Development
        • 14.7.2.3 Sales and Marketing
    • 14.8 Codman & Shurtleff, Inc
      • 14.8.1 Company Overview
    • 14.9 Integra LifeSciences Holdings Corporation
      • 14.9.1 Company Overview
      • 14.9.2 Value Chain Analysis
        • 14.9.2.1 Manufacturing
        • 14.9.2.2 Product Development
        • 14.9.2.3 Sales and Marketing
    • 14.10 OLYMPUS CORPORATION
      • 14.10.1 Company Overview
      • 14.10.2 Value Chain Analysis
        • 14.10.2.1 Manufacturing
        • 14.10.2.2 Product Development
        • 14.10.2.3 Sales and Marketing
    • 14.11 KARL STORZ GmbH & Co. KG
      • 14.11.1 Company Overview
  • 15 Recent Developments
    • 15.1 Product News
      • 15.1.1 Apr 15, 2009: Huashan Hospital Installs IMRIS' 3T Version Of IMRISneuro For Neurosurgery
  • 16 Appendix
    • 16.1 Global Markets Direct Research Methodology
    • 16.2 Coverage
    • 16.3 Secondary Research
    • 16.4 Primary Research
    • 16.5 Models
    • 16.6 Forecasts
    • 16.7 Expert Panel Validation
    • 16.8 Currency Conversion
    • 16.9 Contact Us
    • 16.10 Disclaimer
  • 1 List of Tables
    • Table 1: Doctors by Specialty in China, 2003-2007
    • Table 2: Hospital Wards by Specialty in China, 2003 - 2007
    • Table 3: Healthcare Institutions in China, 2000-2006
    • Table 4: Personnel Employed in Healthcare Institutions in China, 2000-2006
    • Table 5: Healthcare Institutions, Hospital Beds and Employed Personnel by Region in China, 2004
    • Table 6: Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 7: Neurology Devices, China, Overall Revenue ($ mn), 2000-2015
    • Table 8: Neurology Devices, China, Cross-Category Analysis, 2000-2015
    • Table 9: Neurology Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 10: Neurology Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 11: Neurology Devices, China, Category Volume (Units), 2000-2015
    • Table 12: Neurology Devices, China, Category Volume (Units), Historic, 2000-2008
    • Table 13: Neurology Devices, China, Category Volume (Units), Forecast, 2008-2015
    • Table 14: Neurology Devices, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 15: CSF Management, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 16: CSF Management, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 17: CSF Management, China, Volume (Units), Historic, 2000-2008
    • Table 18: CSF Management, China, Volume (Units), Forecast, 2008-2015
    • Table 19: CSF Management, China, Average Price ($), Historic, 2000-2008
    • Table 20: CSF Management, China, Average Price ($), Forecast, 2008-2015
    • Table 21: CSF Management, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 22: CSF Management, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Interventional Neurology, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 24: Interventional Neurology, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 25: Embolic Systems, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 26: Embolic Systems, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 27: Navigational Systems, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 28: Navigational Systems, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 29: Interventional Neurology, China, Volume (Units), Historic, 2000-2008
    • Table 30: Interventional Neurology, China, Volume (Units), Forecast, 2008-2015
    • Table 31: Embolic Systems, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 32: Embolic Systems, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 33: Navigational Systems, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 34: Navigational Systems, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 35: Interventional Neurology, China, Average Price ($), Historic, 2000-2008
    • Table 36: Interventional Neurology, China, Average Price ($), Forecast, 2008-2015
    • Table 37: Interventional Neurology, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 38: Interventional Neurology, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 39: Neurostimulation Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 40: Neurostimulation Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 41: Neurostimulation Devices, China, Volume (Units), Historic, 2000-2008
    • Table 42: Neurostimulation Devices, China, Volume (Units), Forecast, 2008-2015
    • Table 43: Neurostimulation Devices, China, Average Price ($), Historic, 2000-2008
    • Table 44: Neurostimulation Devices, China, Average Price ($), Forecast, 2008-2015
    • Table 45: Neurostimulation Devices, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 46: Neurostimulation Devices, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 47: Neurosurgical Products, China, Revenue ($ mn), Historic, 2000-2008
    • Table 48: Neurosurgical Products, China, Revenue ($ mn), Forecast, 2008-2015
    • Table 49: Neurosurgical Products, China, Volume (Units), Historic, 2000-2008
    • Table 50: Neurosurgical Products, China, Volume (Units), Forecast, 2008-2015
    • Table 51: Neurosurgical Products, China, Average Price ($), Historic, 2000-2008
    • Table 52: Neurosurgical Products, China, Average Price ($), Forecast, 2008-2015
    • Table 53: Neurosurgical Products, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 54: Neurosurgical Products, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 55: Radiosurgery, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 56: Radiosurgery, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 57: Radiosurgery, China, Volume (Units), Historic, 2000-2008
    • Table 58: Radiosurgery, China, Volume (Units), Forecast, 2008-2015
    • Table 59: Radiosurgery, China, Average Price ($), Historic, 2000-2008
    • Table 60: Radiosurgery, China, Average Price ($), Forecast, 2008-2015
    • Table 61: Radiosurgery, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 62: Radiosurgery, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 63: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 64: Medtronic, Inc. Pipeline Products By Development Stage
    • Table 65: Medtronic, Inc. Pipeline Products By Therapy Area
    • Table 66: Medtronic, Inc. Pipeline Products By Clinical Trials
    • Table 67: Medtronic, Inc. Pipeline Products By News Summary
    • Table 68: Boston Scientific Corporation Pipeline Products by Equipment Type
    • Table 69: Boston Scientific Corporation Pipeline Products By Development Stage
    • Table 70: Boston Scientific Corporation Pipeline Products By Therapy Area
    • Table 71: Boston Scientific Corporation Pipeline Products By Clinical Trials
    • Table 72: Boston Scientific Corporation Pipeline Products By News Summary
    • Table 73: Elekta AB Pipeline Products by Equipment Type
    • Table 74: Elekta AB Pipeline Products By Development Stage
    • Table 75: Elekta AB Pipeline Products By Therapy Area
    • Table 76: Elekta AB Pipeline Products By News Summary
    • Table 77: Cyberonics, Inc. Pipeline Products by Equipment Type
    • Table 78: Cyberonics, Inc. Pipeline Products By Development Stage
    • Table 79: Cyberonics, Inc. Pipeline Products By Therapy Area
    • Table 80: ev3 Inc. Pipeline Products by Equipment Type
    • Table 81: ev3 Inc. Pipeline Products By Development Stage
    • Table 82: ev3 Inc. Pipeline Products By Therapy Area
    • Table 83: ev3 Inc. Pipeline Products By Clinical Trials
    • Table 84: ev3 Inc. Pipeline Products By News Summary
    • Table 85: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in China, 2000 2005
    • Figure 2: Medical Equipment Registration Process in China, 2007
    • Figure 3: CCC Mark Certification Process in China, 2007
    • Figure 4: Neurology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 5: Neurology Devices, China, Overall Revenue ($ mn), 2000-2015
    • Figure 6: Neurology Devices, China, Cross-Category Analysis, 2000-2015
    • Figure 7: Neurology Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 8: Neurology Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 9: Neurology Devices, China, Company Share (%), 2007
    • Figure 10: CSF Management, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 11: CSF Management, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 12: CSF Management, China, Volume (Units), Historic, 2000-2008
    • Figure 13: CSF Management, China, Volume (Units), Forecast, 2008-2015
    • Figure 14: CSF Management, China, Company Share (%), 2007
    • Figure 15: Interventional Neurology, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 16: Interventional Neurology, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 17: Embolic Systems, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 18: Embolic Systems, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 19: Navigational Systems, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 20: Navigational Systems, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 21: Interventional Neurology, China, Volume (Units), Historic, 2000-2008
    • Figure 22: Interventional Neurology, China, Volume (Units), Forecast, 2008-2015
    • Figure 23: Embolic Systems, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 24: Embolic Systems, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 25: Navigational Systems, China, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 26: Navigational Systems, China, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 27: Interventional Neurology, China, Company Share (%), 2007
    • Figure 28: Neurostimulation Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 29: Neurostimulation Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 30: Neurostimulation Devices, China, Volume (Units), Historic, 2000-2008
    • Figure 31: Neurostimulation Devices, China, Volume (Units), Forecast, 2008-2015
    • Figure 32: Neurostimulation Devices, China, Company Share (%), 2007
    • Figure 33: Neurosurgical Products, China, Revenue ($ mn, Historic, 2000-2008
    • Figure 34: Neurosurgical Products, China, Revenue ($ mn), Forecast, 2008-2015
    • Figure 35: Neurosurgical Products, China, Volume (Units), Historic, 2000-2008
    • Figure 36: Neurosurgical Products, China, Volume (Units), Forecast, 2008-2015
    • Figure 37: Neurosurgical Products, China, Company Share (%), 2007
    • Figure 38: Radiosurgery, China, Company Share (%), 2007
    • Figure 39: Medtronic, Inc. Value Chain Analysis
    • Figure 40: Boston Scientific Corporation Value Chain Analysis
    • Figure 41: Elekta AB Value Chain Analysis
    • Figure 42: ev3 Inc. Value Chain Analysis
    • Figure 43: B. Braun Melsungen AG Value Chain Analysis
    • Figure 44: Integra LifeSciences Holdings Corporation Value Chain Analysis
    • Figure 45: Olympus Medical Systems Corp. Value Chain Analysis
    • Figure 46: Global Markets Direct Methodology

Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment